KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 132 filers reported holding KALA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $381,000 | -43.4% | 56,500 | -43.1% | 0.00% | -50.0% |
| Q4 2020 | $673,000 | -14.8% | 99,300 | -5.7% | 0.00% | 0.0% |
| Q3 2020 | $790,000 | +71.4% | 105,300 | +139.9% | 0.00% | +100.0% |
| Q2 2020 | $461,000 | +43.2% | 43,900 | +19.9% | 0.00% | 0.0% |
| Q1 2020 | $322,000 | +119.0% | 36,600 | +58.4% | 0.00% | – |
| Q2 2019 | $147,000 | +14.0% | 23,100 | +48.1% | 0.00% | – |
| Q1 2019 | $129,000 | +118.6% | 15,600 | +30.0% | 0.00% | – |
| Q4 2018 | $59,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 1 | $9 | 0.00% |